510(k) K193649
K193649 is an FDA 510(k) premarket notification submitted by HORIBA ABX SAS for the device "Yumizen C1200 Creatinine PAP". The FDA issued a decision of Substantially Equivalent on May 10, 2021. The device falls under product code JFY (Enzymatic Method, Creatinine), a Class II device regulated under 21 CFR 862.1225. HORIBA ABX SAS has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 10, 2021
- Date Received
- December 30, 2019
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzymatic Method, Creatinine
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type